1) radioactive inclusion
放射性夹杂物
2) brittle inclusion
脆性夹杂物
1.
The main causes which lead to tensile abnormal fracture of SWRH82B steel rods are the network cementite and the big brittle inclusion.
通过对SWRH82B盘条的拉伸断口进行分析,认为网状渗碳体和大颗粒脆性夹杂物等缺陷是引起断口异常的主要原因。
2.
By means of microstructure test,chemical composition analysis,fracture test,inclusion spectrum analysis of 80 steel wire rod with lower strength and bigger plasticity variety,the results show that the cause of lower strength is lower content of sorbite and the reasons for bigger plasticity variety are meshy carbides and big grain brittle inclusions inside the wire rod.
通过对强度偏低、塑性变化较大的80钢盘条的金相检验、化学成分分析、断口检验、夹杂物能谱分析,认为其强度偏低的原因是索氏体含量偏低,塑性变化较大的原因是盘条内部存在网状碳化物和大颗粒脆性夹杂物。
3) Modification of Inclusion
夹杂物变性
1.
Effect of Rare-Earth Element Ce on Modification of Inclusion in Stainless Steel 2Cr13;
稀土元素Ce对2Cr13不锈钢中夹杂物变性的影响
2.
Based on the comparison of deoxidation ability of different single element,both the deoxidation ability and modification ability of inclusion of Ba and Ca was analysed and discussed ,the process of deoxidation and modification of inclusion with Ba alloy are advised.
在比较了各种常用脱氧剂单质脱氧能力的基础上,对钙合金、钡合金夹杂的变性能力进行了理论分析和探讨,并对钡合金的脱氧和夹杂物变性工艺提出了建议。
4) inclusion modification
夹杂物变性
1.
Experimental study on inclusion modification in the steel by Mg cored wire feeding process;
镁芯包芯线处理钢水夹杂物变性实验
2.
Influence of remaining calcium amount on inclusion modification after Ca-treatment;
残钙量对夹杂物变性效果的影响
3.
In this experimental research, SiCaBa wire was fed into cool heading steel in order to find out the effect on inclusion modification and total oxygen content, and SiCa wire was also fed as contrastive deoxidizer.
本实验以冷镦钢为实验钢种,在Al和FeSiAl脱氧之后喂SiCaBa包芯线,并以喂SiCa包芯线作为比较实验,以此研究喂SiCaBa线对夹杂物变性控制和全氧含量的影响。
5) plastic inclusions
塑性夹杂物
1.
The relationship of the level of plastic inclusions and the z-direction section shrinkage was also studied.
通过对不同炉批的Q345B板坯在试验轧机上进行轧制,对塑性夹杂物级别与Z向断面收缩率(zψ)之间的关系进行了研究分析,指出塑性夹杂物的数量、大小和形态对钢的Z向断面收缩率起着决定性作用。
6) inclusion conditioning
夹杂物改性
1.
Calcium treatment is effective for inclusion conditioning.
采用转炉出钢“渣洗”方法对钢水脱硫并用钙处理手段对钢中夹杂物进行改性处理,结果表明:在转炉出钢过程中采用“渣洗”脱硫方法可有效降低钢水硫含量;钙处理可使钢中夹杂物改性,从而提高钢材的使用性能。
补充资料：放射性碘标记的放射性药物
分子式：
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条